Aster DM Healthcare Ltd

AGM details

• Date/time/mode: 28 Sep 2026, 11:30 IST, via video conferencing (VC).
• Proceedings recorded and posted; NSDL livestreamed the meeting.

Resolutions

• Resolution 1 (Ordinary): Adopt audited financial statements for year ended March 31, 2026.
• Resolution 2 (Ordinary): Reappoint director T. J. Wilson, retiring by rotation.
• Resolution 3 (Ordinary): Ratify cost auditors' remuneration for FY2026-27.
• Resolution 4 (Special): Increase limits under Section 185 of the Companies Act, 2013.
• Resolution 5 (Special): Increase limits under Section 186 of the Companies Act, 2013.

Voting status

• Voting results not disclosed; final results to be submitted to exchanges and NSDL site.

Dividend

• Interim dividend of Rs 3 per equity share declared and paid.
• Total payout approx Rs 155 crore; no final dividend proposed.

Director changes

• T. J. Wilson to be reappointed; retires by rotation.

Auditors

• Cost auditors' remuneration for FY2026-27 to be ratified.

Merger update

• Merger became effective July 1, 2026, forming Aster DM Quality Care Limited.

Expansion plan

• Plan to add around 4,200 beds; Brownfield 53%, Greenfield 47%.
• Network to reach about 15,000 beds.

AGM details

• AGM date/time: 28 September 2026, 11:30 AM–1:26 PM (VC).
• Record date for voting entitlements: 21 September 2026.
• Mode: Video Conferencing.

Resolutions and outcomes

• Item 1 Ordinary: Adopt Audited Financial Statements; passed.
• Item 2 Ordinary: Re-appointment by rotation of Mr. Wilson; passed.
• Item 3 Ordinary: Ratify remuneration to Cost Auditors for FY ending 31 March 2027; passed.
• Item 4 Special: Increase limits under Section 185; passed.
• Item 5 Special: Increase limits under Section 186; passed.

Director and auditor actions

• Director TJ Wilson re-appointment approved.
• Cost Auditor remuneration ratified for FY 2027.

Governance and voting process

• Scrutinizer report submitted by Beyond Compliance Corporate Services Pvt Ltd.
• e-Voting window: 25–27 Sep 2026; AGM votes on 28 Sep 2026.

Board and committee changes

• Retirement of Purana Housdurgam Vijayadeepti as Non-Executive Independent Director, effective at AGM conclusion 28 Sep 2026.
• Ceases as Chairperson of the Risk Management and Technology Steering Committees.
• Ceases as member of Nomination and Remuneration Committee and CSR Committee.
• Neela Bhattacherjee appointed Additional Director, Non-Executive Independent, effective 28 Sep 2026.
• Three-year term for Neela Bhattacherjee, subject to shareholder approval by Special Resolution.
• Neeraj Jain appointed Chairman of the Risk Management Committee.
• Neela Bhattacherjee appointed as Member of Nomination and Remuneration Committee.
• Sunil Theckath Vasudevan appointed Member of Corporate Social Responsibility Committee.
• Neela Bhattacherjee not related to any Director and not debarred.
• Profile: 32+ years in IT/ITES; strategy, M&A, leadership; mentoring professionals.

AGM Details

• Date 28 September 2026, 11:30 IST; mode: Video Conferencing.

Resolutions

• Adopt Audited Standalone and Consolidated Financial Statements for FY2025-26 with reports; results to be submitted separately.
• Re-appoint director by rotation: Mr. T J Wilson retires and offers himself for re-appointment; results to be announced.
• Ratify remuneration of Cost Auditors for FY ending 31 March 2027; results to be announced.
• Increase limits under Section 185 of the Companies Act, 2013; results to be announced.
• Increase limits under Section 186 of the Companies Act, 2013; results to be announced.

Voting Status

• Voting results to be submitted separately to stock exchanges.

Aster DM Quality Care Limited: Trading window closed from 1 October 2026 until 48 hours from the date of declaration of unaudited financial results (standalone and consolidated) for the quarter and half year ending 30 September 2026

Resolutions and outcomes

• Purpose: Postal ballot to approve MD/CEO appointment, directors, remuneration, and ESOP schemes.
• Ordinary: Appoint Varun Shadilal Khanna as Managing Director and Group CEO; remuneration approved; 99.27% in favour.
• Ordinary: Appoint Ayshwarya Ravi Vikram as Non-Executive Non-Independent Director; 99.72% in favour.
• Ordinary: Appoint Ganesh Mani as Non-Executive Non-Independent Director; 99.89% in favour.
• Special: Appoint Neeraj Jain as Non-Executive Independent Director; 99.33% in favour.
• Special: Appoint Kewal Kundanlal Handa as Non-Executive Independent Director; 99.09% in favour.
• Special: Appoint Valayil Korath Mathews as Non-Executive Independent Director; 99.68% in favour.
• Special: Revise managerial remuneration of Dr. Mandayapurath Azad Moopen, Executive Chairman; 99.69% in favour.
• Special: Change designation of Alisha Moopen to Executive Director; remuneration revised; 94.87% in favour.
• Special: Approve ESOP Scheme 2026 for employees; 88.75% in favour.
• Special: Extend ESOP benefits to subsidiary employees and directors; 88.75% in favour.

Capital allocation timetable

• Indicative deployment: FY27 ~INR 1,900 crore; FY28 ~INR 3,000 crore.
• FY29 indicative deployment ~INR 2,000 crore for subsidiaries and strategic initiatives.
• Schedule is indicative and may vary due to business needs and approvals.

Rating Action Details

• Long-term fund-based cash credit: upgraded to AA(Stable) from AA-; rating watch removed; Rs 19 crore.
• Long-term fund-based term loan: upgraded to AA(Stable) from AA-; rating watch removed; Rs 75 crore.
• Short-term fund-based - others: A1+; reaffirmed; rating watch removed; Rs 12 crore.
• Unallocated: AA(Stable)/A1+; long-term upgrade from AA-; short-term reaffirmed; Rs 104 crore.
• Merger completion of QCIL into ADMQCL enabled KHML upgrade.

Rationale and Key Metrics

• Consolidated view of KHML and KNIMSPL; implicit parent support from ADMQCL.
• Post-merger, larger scale and diversification improved ARPOB and earnings.
• FY2026 revenue grew ~23%; OPM 30.2%.
• Debt metrics improved: TD/OPBDIT 0.4x; interest coverage 23.4x; DSCR 8.3x.
• Liquidity strong: Rs 225–235 crore cash; Rs 30.9 crore unutilised WC.
• Capex Rs 150–200 crore in FY2027; funded by debt and internal accruals.
• Concentration risk: Trivandrum hospital ~70% revenue; ~75% OPBITDA.
• Regulatory and competition risk; doctors retention challenges.
• Outlook: Stable; support from parent expected.
• Rating sensitivities: upgrades with scale/occupancy/ARPOB; downgrades if debt-funded capex weakens metrics.

Encumbrance release and hold in Aster DM Quality Care

• Target Company: Aster DM Quality Care Limited (Formerly Aster DM Healthcare Limited).
• Disclosing Party: Catalyst Trusteeship Limited (not promoter group).
• Transaction Type: Release of encumbrance and creation of hold over shares.
• Pre-Transaction Holding: Encumbered 8,50,96,820 shares (9.76%); voting rights NIL.
• Transaction Details: Encumbrance released 1,99,80,522; hold created over 2,49,77,319; net +49,96,797.
• Post-Transaction Holding: Encumbered 9,00,93,617 shares (10.33%); voting rights NIL.
• Dates: 7 Sep 2026 (encumbrance release); 9 Sep 2026 (hold creation).
• Share Capital Context: Before/after equity shares 871,672,439; diluted capital 871,672,439.

Event Overview

• Creation of non-disposal undertaking over 100% UMHL shares; release of previous encumbrance.

Key Details

• Target: Aster DM Quality Care Limited (formerly Aster DM Healthcare Limited).
• Encumbrance type: Non-disposal undertaking.
• Encumbered shares: 2,49,77,319 (2.86%).
• Promoter: Union (Mauritius) Holdings Limited (UMHL).
• Encumbrance in favour: Catalyst Trusteeship Limited as Onshore Security Agent.
• Lenders: Barclays Bank PLC and JPMorgan Chase Bank N.A., London Branch.
• Reason: To secure facilities of USD 160m and USD 50m.
• End use: Facility A for UIPL; Facility B for inter-company loan to UMHL.
• Date of encumbrance: 07 September 2026.

Notes

• Indirect encumbrance disclosed Aug 26, 2026 via pledge over 100% UMHL shares held by individuals.
• Facility A increased from USD 145m to USD 160m; Facility B USD 50m.